Participants in a new study had inherited genetic variants that lead to early-onset Alzheimer’s. Among those who received the drug the longest – an average of eight years – the treatment lowered the risk of developing symptoms from essentially 100% to about 50%.
The new Alzheimer’s antibodies, Leqembi and Kisunla, work better on some people than others. A cutting-edge technique called spatial transcriptomics may help figure out how to make them work better for everybody.
A new study shows ultrasound improves memory even when amyloid plaque levels don’t improve. (Amyloid is the culprit behind Alzheimer’s.) Could ultrasound be the missing piece in the Alzheimer’s puzzle?
See Lady Liv, the first AI avatar born from real people’s lived experiences with dementia. Watch ‘Liv’ help those recently diagnosed, by answering questions only a peer who shares the experience of Alzheimer’s would know.
With so much going on in the field of Alzheimer’s, watch expert Dr. Charles Bernick give a short sum-up of the latest in treatment and prevention!
Right now, there are two FDA approved drugs to treat Alzheimer’s itself. Find out why Remternetug may soon get approval as a third, even better treatment.
Diabetes and prediabetes are dementia risk factors. They affect 1 in 7 adults! Learn about new research to lower that risk with lifestyle and drugs.
Is amyloid-beta plaque behind Alzheimer’s? A famous study proved “Yes”. Then news broke proving the study a fraud. Yet today’s best, newest Alzheimer’s drugs work by fighting plaque. Did fabricated scientific results accidentally set us on the path to a breakthrough?
AAIC 2024 is the Alzheimer’s Association’s International Conference. The world’s leading scientists, researchers, and clinicians gather to discuss the latest discoveries and upcoming research. Ranging from new biomarker blood tests to VR technology, see exciting and promising news coming from the 2024 conference.
Head-to-head study examined which blood tests most accurately detected amyloid plaques and other Alzheimer’s-related measures.
Participants in a new study had inherited genetic variants that lead to early-onset Alzheimer’s. Among those who received the drug the longest – an average of eight years – the treatment lowered the risk of developing symptoms from essentially 100% to about 50%.
Blueberries can significantly improve cognitive performance within hours of consumption. Watch Dr. Greger on NutritionFacts.org to see how much.
Researchers found that spending time with horses — equine therapy — eases Alzheimer’s symptoms. Find out why.
EXTRAORDINARY MUSIC VIDEO: Ted McDermott, The Song-A-Minute Man, was diagnosed with dementia. His son, Simon, wasn’t going to let that stop his Dad. He understood how music reaches our deepest selves and has journeyed with his Dad and their dashcam to make beautiful music together. Get your widest smile ready and watch them in action.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
